|
Bio Expo Online / Name Reactions / Gomberg-Bachmann reaction
Aesica Pharmaceuticals Limited
United Kingdom
Our state-of-the-art technology offers the capability to manufacture development compounds in quantities for use in Phase I to III clinical trials or for high volume continuous supplies. We will carry out all your IND/CMC requirements from the preclinical stage right through to commercial supply.
AllessaChemie GmbH
Germany
Thirty technologies are the basis for AllessasChemie’s product range of 700 organic intermediates. Together with AllessaSyntec, the scale-up from laboratory to technical scale to 50 tons per year can be provided.
|
